- Home
- GSHD vs PTGX Comparison
GSHD vs PTGX Comparison
Compare GSHD & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHD
- PTGX
- Stock Information
- Founded
- GSHD 2003
- PTGX 2006
- Country
- GSHD United States
- PTGX United States
- Employees
- GSHD N/A
- PTGX N/A
- Industry
- GSHD Specialty Insurers
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- GSHD Finance
- PTGX Health Care
- Exchange
- GSHD Nasdaq
- PTGX Nasdaq
- Market Cap
- GSHD 2.6B
- PTGX 2.7B
- IPO Year
- GSHD 2018
- PTGX 2016
- Fundamental
- Price
- GSHD $104.94
- PTGX $39.30
- Analyst Decision
- GSHD Buy
- PTGX Strong Buy
- Analyst Count
- GSHD 12
- PTGX 8
- Target Price
- GSHD $95.33
- PTGX $54.63
- AVG Volume (30 Days)
- GSHD 206.4K
- PTGX 691.2K
- Earning Date
- GSHD 02-19-2025
- PTGX 11-07-2024
- Dividend Yield
- GSHD N/A
- PTGX N/A
- EPS Growth
- GSHD 46.50
- PTGX N/A
- EPS
- GSHD 0.68
- PTGX 2.68
- Revenue
- GSHD $282,564,000.00
- PTGX $323,795,000.00
- Revenue This Year
- GSHD $17.43
- PTGX $441.08
- Revenue Next Year
- GSHD $25.28
- PTGX N/A
- P/E Ratio
- GSHD $155.29
- PTGX $14.65
- Revenue Growth
- GSHD 11.18
- PTGX 125.73
- 52 Week Low
- GSHD $50.47
- PTGX $21.43
- 52 Week High
- GSHD $130.39
- PTGX $48.89
- Technical
- Relative Strength Index (RSI)
- GSHD 28.73
- PTGX 41.13
- Support Level
- GSHD $103.38
- PTGX $38.61
- Resistance Level
- GSHD $118.20
- PTGX $41.68
- Average True Range (ATR)
- GSHD 3.91
- PTGX 1.80
- MACD
- GSHD -2.33
- PTGX -0.02
- Stochastic Oscillator
- GSHD 6.67
- PTGX 15.54
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.